MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression
- PMID: 30656427
- DOI: 10.1007/s10120-019-00924-0
MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression
Abstract
Background: Semaphorin 3B (SEMA3B) is frequently inactivated in several carcinomas. However, as the host gene of miR-6872, the roles of SEMA3B, antisense lncRNA SEMA3B-AS1, and miR-6872 in gastric cardia adenocarcinoma (GCA) tumorigenesis have not been clarified.
Methods: The expression levels of SEMA3B, SEMA3B-AS1, and miR-6872 were respectively detected by qRT-PCR, western blot, or immunohistochemical staining assays. The methylation status was determined by BGS and BS-MSP methods. In vitro assays were preformed to explore the biological effects of SEMA3B, SEMA3B-AS1, and miR-6872-5p in gastric cancer cells. Chromatin immunoprecipitation assay was used to detect the binding of protein to DNA. The interaction of SEMA3B-AS1 with MLL4 was identified by RNA immunoprecipitation and RNA pull-down assays.
Results: Frequent downregulation of SEMA3B, SEMA3B-AS1, and miR-6872 was detected in GCA tissues and gastric cancer cells. Aberrant hypermethylation of the promoter region was more tumor specific and was negatively correlated with the expression level of SEMA3B, SEMA3B-AS1, and miR-6872-5p. Transcription factor Sp1 activated SEMA3B or SEMA3B-AS1 transcription and CpG sites hypermethylation within promoter region eliminated Sp1 binding ability. Overexpression of SEMA3B and SEMA3B-AS1 inhibited gastric cancer cell proliferation, migration, and invasion in vitro. SEMA3B-AS1 induced the expression of SEMA3B by interacting with MLL4. ZNF143 might be the target gene of miR-6872-5p and miR-6872-5p functioning synergistically with SEMA3B to suppress cell invasion. Furthermore, SEMA3B, SEMA3B-AS1, and miR-6872-5p expression levels were associated with GCA patients' survival.
Conclusions: SEMA3B, SEMA3B-AS1, and miR-6872 may act as tumor suppressors and may serve as potential targets for antitumor therapy.
Keywords: Expression; Gastric cardia adenocarcinoma; MiR-6872; SEMA3B; SEMA3B-AS1.
Similar articles
-
Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma.Clin Exp Metastasis. 2019 Jun;36(3):225-241. doi: 10.1007/s10585-019-09964-3. Epub 2019 Mar 27. Clin Exp Metastasis. 2019. PMID: 30915595
-
Aberrant methylation-mediated downregulation of long noncoding RNA C5orf66-AS1 promotes the development of gastric cardia adenocarcinoma.Mol Carcinog. 2018 Jul;57(7):854-865. doi: 10.1002/mc.22806. Epub 2018 Apr 6. Mol Carcinog. 2018. PMID: 29566283
-
Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma.Mol Carcinog. 2017 Aug;56(8):1924-1934. doi: 10.1002/mc.22650. Epub 2017 Apr 13. Mol Carcinog. 2017. PMID: 28345805
-
Knockdown of lncRNA MFI2-AS1 inhibits lipopolysaccharide-induced osteoarthritis progression by miR-130a-3p/TCF4.Life Sci. 2020 Jan 1;240:117019. doi: 10.1016/j.lfs.2019.117019. Epub 2019 Oct 31. Life Sci. 2020. PMID: 31678554 Review.
-
A review on the role of NCK1 Antisense RNA 1 (NCK1-AS1) in diverse disorders.Pathol Res Pract. 2023 May;245:154451. doi: 10.1016/j.prp.2023.154451. Epub 2023 Apr 5. Pathol Res Pract. 2023. PMID: 37028107 Review.
Cited by
-
lncSAMM50 Enhances Adipogenic Differentiation of Buffalo Adipocytes With No Effect on Its Host Gene.Front Genet. 2021 Mar 26;12:626158. doi: 10.3389/fgene.2021.626158. eCollection 2021. Front Genet. 2021. PMID: 33841496 Free PMC article.
-
Long non-coding RNAs in gastric cancer: New emerging biological functions and therapeutic implications.Theranostics. 2020 Jul 11;10(19):8880-8902. doi: 10.7150/thno.47548. eCollection 2020. Theranostics. 2020. PMID: 32754285 Free PMC article. Review.
-
LncRNA SEMA3B-AS1 inhibits breast cancer progression by targeting miR-3940/KLLN axis.Cell Death Dis. 2022 Sep 19;13(9):800. doi: 10.1038/s41419-022-05189-7. Cell Death Dis. 2022. PMID: 36123344 Free PMC article.
-
A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer.Front Immunol. 2022 Aug 5;13:929846. doi: 10.3389/fimmu.2022.929846. eCollection 2022. Front Immunol. 2022. PMID: 35990656 Free PMC article.
-
Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer.Theranostics. 2021 Jan 15;11(7):3262-3277. doi: 10.7150/thno.54023. eCollection 2021. Theranostics. 2021. PMID: 33537086 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous